ID   GLMU_ECOLI              Reviewed;         456 AA.
AC   P0ACC7; P17114; P76746; Q2M848;
DT   08-NOV-2005, integrated into UniProtKB/Swiss-Prot.
DT   08-NOV-2005, sequence version 1.
DT   15-MAR-2017, entry version 109.
DE   RecName: Full=Bifunctional protein GlmU {ECO:0000255|HAMAP-Rule:MF_01631};
DE   Includes:
DE     RecName: Full=UDP-N-acetylglucosamine pyrophosphorylase {ECO:0000255|HAMAP-Rule:MF_01631};
DE              EC=2.7.7.23 {ECO:0000255|HAMAP-Rule:MF_01631, ECO:0000269|PubMed:10428949, ECO:0000269|PubMed:8083170, ECO:0000269|PubMed:8555230};
DE     AltName: Full=N-acetylglucosamine-1-phosphate uridyltransferase {ECO:0000255|HAMAP-Rule:MF_01631};
DE   Includes:
DE     RecName: Full=Glucosamine-1-phosphate N-acetyltransferase {ECO:0000255|HAMAP-Rule:MF_01631};
DE              EC=2.3.1.157 {ECO:0000255|HAMAP-Rule:MF_01631, ECO:0000269|PubMed:10428949, ECO:0000269|PubMed:8083170, ECO:0000269|PubMed:8555230};
GN   Name=glmU {ECO:0000255|HAMAP-Rule:MF_01631}; Synonyms=yieA;
GN   OrderedLocusNames=b3730, JW3708;
OS   Escherichia coli (strain K12).
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Enterobacterales;
OC   Enterobacteriaceae; Escherichia.
OX   NCBI_TaxID=83333;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=6395859; DOI=10.1042/bj2240799;
RA   Walker J.E., Gay N.J., Saraste M., Eberle A.N.;
RT   "DNA sequence around the Escherichia coli unc operon. Completion of
RT   the sequence of a 17 kilobase segment containing asnA, oriC, unc, glmS
RT   and phoS.";
RL   Biochem. J. 224:799-815(1984).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / MG1655 / ATCC 47076;
RX   PubMed=7686882; DOI=10.1006/geno.1993.1230;
RA   Burland V.D., Plunkett G. III, Daniels D.L., Blattner F.R.;
RT   "DNA sequence and analysis of 136 kilobases of the Escherichia coli
RT   genome: organizational symmetry around the origin of replication.";
RL   Genomics 16:551-561(1993).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND SEQUENCE REVISION.
RC   STRAIN=K12 / MG1655 / ATCC 47076;
RX   PubMed=9278503; DOI=10.1126/science.277.5331.1453;
RA   Blattner F.R., Plunkett G. III, Bloch C.A., Perna N.T., Burland V.,
RA   Riley M., Collado-Vides J., Glasner J.D., Rode C.K., Mayhew G.F.,
RA   Gregor J., Davis N.W., Kirkpatrick H.A., Goeden M.A., Rose D.J.,
RA   Mau B., Shao Y.;
RT   "The complete genome sequence of Escherichia coli K-12.";
RL   Science 277:1453-1462(1997).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / W3110 / ATCC 27325 / DSM 5911;
RX   PubMed=16738553; DOI=10.1038/msb4100049;
RA   Hayashi K., Morooka N., Yamamoto Y., Fujita K., Isono K., Choi S.,
RA   Ohtsubo E., Baba T., Wanner B.L., Mori H., Horiuchi T.;
RT   "Highly accurate genome sequences of Escherichia coli K-12 strains
RT   MG1655 and W3110.";
RL   Mol. Syst. Biol. 2:E1-E5(2006).
RN   [5]
RP   IDENTIFICATION.
RX   PubMed=8407787; DOI=10.1128/jb.175.19.6150-6157.1993;
RA   Mengin-Lecreulx D., van Heijenoort J.;
RT   "Identification of the glmU gene encoding N-acetylglucosamine-1-
RT   phosphate uridyltransferase in Escherichia coli.";
RL   J. Bacteriol. 175:6150-6157(1993).
RN   [6]
RP   FUNCTION, CATALYTIC ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES, AND
RP   ENZYME REGULATION.
RX   PubMed=8083170; DOI=10.1128/jb.176.18.5788-5795.1994;
RA   Mengin-Lecreulx D., van Heijenoort J.;
RT   "Copurification of glucosamine-1-phosphate acetyltransferase and N-
RT   acetylglucosamine-1-phosphate uridyltransferase activities of
RT   Escherichia coli: characterization of the glmU gene product as a
RT   bifunctional enzyme catalyzing two subsequent steps in the pathway for
RT   UDP-N-acetylglucosamine synthesis.";
RL   J. Bacteriol. 176:5788-5795(1994).
RN   [7]
RP   FUNCTION, CATALYTIC ACTIVITY, SUBSTRATE SPECIFICITY, AND
RP   BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=8555230; DOI=10.1021/bi952275a;
RA   Gehring A.M., Lees W.J., Mindiola D.J., Walsh C.T., Brown E.D.;
RT   "Acetyltransfer precedes uridylyltransfer in the formation of UDP-N-
RT   acetylglucosamine in separable active sites of the bifunctional GlmU
RT   protein of Escherichia coli.";
RL   Biochemistry 35:579-585(1996).
RN   [8]
RP   MUTAGENESIS OF CYS-296; CYS-307; CYS-324 AND CYS-385, AND
RP   BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=9733680;
RA   Pompeo F., van Heijenoort J., Mengin-Lecreulx D.;
RT   "Probing the role of cysteine residues in glucosamine-1-phosphate
RT   acetyltransferase activity of the bifunctional protein glmU from
RT   Escherichia coli: site-directed mutagenesis and characterization of
RT   the mutant enzymes.";
RL   J. Bacteriol. 180:4799-4803(1998).
RN   [9]
RP   X-RAY CRYSTALLOGRAPHY (2.25 ANGSTROMS) OF THE TRUNCATED FORM AND IN
RP   COMPLEX WITH UDP-GLCNAC, FUNCTION, CATALYTIC ACTIVITY,
RP   BIOPHYSICOCHEMICAL PROPERTIES, MUTAGENESIS OF GLY-14; ARG-18 AND
RP   LYS-25, SUBCELLULAR LOCATION, AND SUBUNIT.
RX   PubMed=10428949; DOI=10.1093/emboj/18.15.4096;
RA   Brown K., Pompeo F., Dixon S., Mengin-Lecreulx D., Cambillau C.,
RA   Bourne Y.;
RT   "Crystal structure of the bifunctional N-acetylglucosamine 1-phosphate
RT   uridyltransferase from Escherichia coli: a paradigm for the related
RT   pyrophosphorylase superfamily.";
RL   EMBO J. 18:4096-4107(1999).
RN   [10]
RP   X-RAY CRYSTALLOGRAPHY (2.1 ANGSTROMS) IN COMPLEX WITH UDP-GLCNAC; COA
RP   AND COBALT ION, COFACTOR, AND SUBUNIT.
RX   PubMed=11329257; DOI=10.1021/bi002503n;
RA   Olsen L.R., Roderick S.L.;
RT   "Structure of the Escherichia coli glmU pyrophosphorylase and
RT   acetyltransferase active sites.";
RL   Biochemistry 40:1913-1921(2001).
RN   [11]
RP   X-RAY CRYSTALLOGRAPHY (2.25 ANGSTROMS) IN COMPLEX WITH UDP-GLCNAC, COA
RP   AND MAGNESIUM IONS, COFACTOR, AND SUBUNIT.
RX   PubMed=17473010; DOI=10.1110/ps.072779707;
RA   Olsen L.R., Vetting M.W., Roderick S.L.;
RT   "Structure of the E. coli bifunctional GlmU acetyltransferase active
RT   site with substrates and products.";
RL   Protein Sci. 16:1230-1235(2007).
RN   [12]
RP   X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS) OF 233-452 ACETYL-COA ANALOG,
RP   FUNCTION, ENZYME REGULATION, AND SUBUNIT.
RX   PubMed=21984832; DOI=10.1074/jbc.M111.274068;
RA   Buurman E.T., Andrews B., Gao N., Hu J., Keating T.A., Lahiri S.,
RA   Otterbein L.R., Patten A.D., Stokes S.S., Shapiro A.B.;
RT   "In vitro validation of acetyltransferase activity of GlmU as an
RT   antibacterial target in Haemophilus influenzae.";
RL   J. Biol. Chem. 286:40734-40742(2011).
RN   [13]
RP   X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF 227-456, FUNCTION, ENZYME
RP   REGULATION, AND SUBUNIT.
RX   PubMed=22297115; DOI=10.1016/j.bmcl.2012.01.016;
RA   Green O.M., McKenzie A.R., Shapiro A.B., Otterbein L., Ni H.,
RA   Patten A., Stokes S., Albert R., Kawatkar S., Breed J.;
RT   "Inhibitors of acetyltransferase domain of N-acetylglucosamine-1-
RT   phosphate-uridyltransferase/glucosamine-1-phosphate-acetyltransferase
RT   (GlmU). Part 1: Hit to lead evaluation of a novel arylsulfonamide
RT   series.";
RL   Bioorg. Med. Chem. Lett. 22:1510-1519(2012).
CC   -!- FUNCTION: Catalyzes the last two sequential reactions in the de
CC       novo biosynthetic pathway for UDP-N-acetylglucosamine (UDP-
CC       GlcNAc). The C-terminal domain catalyzes the transfer of acetyl
CC       group from acetyl coenzyme A to glucosamine-1-phosphate (GlcN-1-P)
CC       to produce N-acetylglucosamine-1-phosphate (GlcNAc-1-P), which is
CC       converted into UDP-GlcNAc by the transfer of uridine 5-
CC       monophosphate (from uridine 5-triphosphate), a reaction catalyzed
CC       by the N-terminal domain. {ECO:0000255|HAMAP-Rule:MF_01631,
CC       ECO:0000269|PubMed:10428949, ECO:0000269|PubMed:21984832,
CC       ECO:0000269|PubMed:22297115, ECO:0000269|PubMed:8083170,
CC       ECO:0000269|PubMed:8555230}.
CC   -!- CATALYTIC ACTIVITY: Acetyl-CoA + alpha-D-glucosamine 1-phosphate =
CC       CoA + N-acetyl-alpha-D-glucosamine 1-phosphate.
CC       {ECO:0000255|HAMAP-Rule:MF_01631, ECO:0000269|PubMed:10428949,
CC       ECO:0000269|PubMed:8083170, ECO:0000269|PubMed:8555230}.
CC   -!- CATALYTIC ACTIVITY: UTP + N-acetyl-alpha-D-glucosamine 1-phosphate
CC       = diphosphate + UDP-N-acetyl-alpha-D-glucosamine.
CC       {ECO:0000255|HAMAP-Rule:MF_01631, ECO:0000269|PubMed:10428949,
CC       ECO:0000269|PubMed:8083170, ECO:0000269|PubMed:8555230}.
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000269|PubMed:17473010};
CC       Name=Co(2+); Xref=ChEBI:CHEBI:48828;
CC         Evidence={ECO:0000269|PubMed:11329257};
CC       Note=Binds 1 Mg(2+) ion per subunit (PubMed:17473010). Can also
CC       use Co(2+) ion to a lesser extent (PubMed:11329257).
CC       {ECO:0000269|PubMed:11329257, ECO:0000269|PubMed:17473010};
CC   -!- ENZYME REGULATION: Inhibited by its reaction product N-
CC       acetylglucosamine-1-phosphate and by UDP-N-acetylmuramic acid,
CC       which is one of the first precursors specific for the
CC       peptidoglycan pathway. {ECO:0000269|PubMed:21984832,
CC       ECO:0000269|PubMed:22297115, ECO:0000269|PubMed:8083170}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=0.018 mM for N-acetylglucosamine 1-phosphate
CC         {ECO:0000269|PubMed:8083170, ECO:0000269|PubMed:8555230,
CC         ECO:0000269|PubMed:9733680};
CC         KM=0.07 mM for alpha-D-glucosamine 1-phosphate
CC         {ECO:0000269|PubMed:10428949};
CC         KM=0.1 mM for UTP {ECO:0000269|PubMed:10428949};
CC         KM=0.15 mM for alpha-D-glucosamine 1-phosphate
CC         {ECO:0000269|PubMed:8083170, ECO:0000269|PubMed:8555230,
CC         ECO:0000269|PubMed:9733680};
CC         KM=0.25 mM for alpha-D-glucosamine 1-phosphate
CC         {ECO:0000269|PubMed:8083170, ECO:0000269|PubMed:8555230,
CC         ECO:0000269|PubMed:9733680};
CC         KM=0.32 mM for acetyl-CoA {ECO:0000269|PubMed:8083170,
CC         ECO:0000269|PubMed:8555230, ECO:0000269|PubMed:9733680};
CC         KM=0.6 mM for acetyl-CoA {ECO:0000269|PubMed:8083170,
CC         ECO:0000269|PubMed:8555230, ECO:0000269|PubMed:9733680};
CC         KM=0.84 mM for n-propionyl-CoA {ECO:0000269|PubMed:8083170,
CC         ECO:0000269|PubMed:8555230, ECO:0000269|PubMed:9733680};
CC         KM=1.3 mM for UDP-glucosamine {ECO:0000269|PubMed:8083170,
CC         ECO:0000269|PubMed:8555230, ECO:0000269|PubMed:9733680};
CC         KM=2 mM for glucose-1-P {ECO:0000269|PubMed:8083170,
CC         ECO:0000269|PubMed:8555230, ECO:0000269|PubMed:9733680};
CC         KM=3.7 mM for N-acetylgalactosamine-1-P
CC         {ECO:0000269|PubMed:8083170, ECO:0000269|PubMed:8555230,
CC         ECO:0000269|PubMed:9733680};
CC         KM=15 mM for galactosamine-1-phosphate
CC         {ECO:0000269|PubMed:8083170, ECO:0000269|PubMed:8555230,
CC         ECO:0000269|PubMed:9733680};
CC   -!- PATHWAY: Nucleotide-sugar biosynthesis; UDP-N-acetyl-alpha-D-
CC       glucosamine biosynthesis; N-acetyl-alpha-D-glucosamine 1-phosphate
CC       from alpha-D-glucosamine 6-phosphate (route II): step 2/2.
CC       {ECO:0000255|HAMAP-Rule:MF_01631}.
CC   -!- PATHWAY: Nucleotide-sugar biosynthesis; UDP-N-acetyl-alpha-D-
CC       glucosamine biosynthesis; UDP-N-acetyl-alpha-D-glucosamine from N-
CC       acetyl-alpha-D-glucosamine 1-phosphate: step 1/1.
CC       {ECO:0000255|HAMAP-Rule:MF_01631}.
CC   -!- PATHWAY: Bacterial outer membrane biogenesis; LPS lipid A
CC       biosynthesis. {ECO:0000255|HAMAP-Rule:MF_01631}.
CC   -!- SUBUNIT: Homotrimer. In vivo forms a hexameric aggregate.
CC       {ECO:0000269|PubMed:10428949, ECO:0000269|PubMed:11329257,
CC       ECO:0000269|PubMed:17473010, ECO:0000269|PubMed:21984832,
CC       ECO:0000269|PubMed:22297115}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000255|HAMAP-Rule:MF_01631,
CC       ECO:0000269|PubMed:10428949}.
CC   -!- SIMILARITY: In the N-terminal section; belongs to the N-
CC       acetylglucosamine-1-phosphate uridyltransferase family.
CC       {ECO:0000255|HAMAP-Rule:MF_01631, ECO:0000305}.
CC   -!- SIMILARITY: In the C-terminal section; belongs to the transferase
CC       hexapeptide repeat family. {ECO:0000255|HAMAP-Rule:MF_01631,
CC       ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAA62081.1; Type=Frameshift; Positions=179; Note=Produces two ORFs.; Evidence={ECO:0000305};
CC       Sequence=AAA62082.1; Type=Frameshift; Positions=179; Note=Produces two ORFs.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X01631; CAA25784.1; -; Genomic_DNA.
DR   EMBL; L10328; AAA62082.1; ALT_FRAME; Genomic_DNA.
DR   EMBL; L10328; AAA62081.1; ALT_FRAME; Genomic_DNA.
DR   EMBL; U00096; AAC76753.1; -; Genomic_DNA.
DR   EMBL; AP009048; BAE77558.1; -; Genomic_DNA.
DR   PIR; C65176; C65176.
DR   RefSeq; NP_418186.1; NC_000913.3.
DR   RefSeq; WP_000933736.1; NZ_LN832404.1.
DR   PDB; 1FWY; X-ray; 2.30 A; A/B=1-331.
DR   PDB; 1FXJ; X-ray; 2.25 A; A/B=1-331.
DR   PDB; 1HV9; X-ray; 2.10 A; A/B=1-456.
DR   PDB; 2OI5; X-ray; 2.25 A; A/B=1-456.
DR   PDB; 2OI6; X-ray; 2.20 A; A/B=1-456.
DR   PDB; 2OI7; X-ray; 2.54 A; A/B=1-456.
DR   PDB; 3TWD; X-ray; 1.90 A; A/B=233-452.
DR   PDB; 4AA7; X-ray; 2.00 A; A/B=227-456.
DR   PDBsum; 1FWY; -.
DR   PDBsum; 1FXJ; -.
DR   PDBsum; 1HV9; -.
DR   PDBsum; 2OI5; -.
DR   PDBsum; 2OI6; -.
DR   PDBsum; 2OI7; -.
DR   PDBsum; 3TWD; -.
DR   PDBsum; 4AA7; -.
DR   ProteinModelPortal; P0ACC7; -.
DR   SMR; P0ACC7; -.
DR   BioGrid; 4262143; 306.
DR   DIP; DIP-31844N; -.
DR   IntAct; P0ACC7; 19.
DR   MINT; MINT-1252604; -.
DR   STRING; 511145.b3730; -.
DR   BindingDB; P0ACC7; -.
DR   ChEMBL; CHEMBL3414415; -.
DR   DrugBank; DB03814; 2-(N-Morpholino)-Ethanesulfonic Acid.
DR   DrugBank; DB01992; Coenzyme A.
DR   DrugBank; DB03397; Uridine-Diphosphate-N-Acetylglucosamine.
DR   PaxDb; P0ACC7; -.
DR   PRIDE; P0ACC7; -.
DR   EnsemblBacteria; AAC76753; AAC76753; b3730.
DR   EnsemblBacteria; BAE77558; BAE77558; BAE77558.
DR   GeneID; 948246; -.
DR   KEGG; ecj:JW3708; -.
DR   KEGG; eco:b3730; -.
DR   PATRIC; 32122957; VBIEscCol129921_3854.
DR   EchoBASE; EB1184; -.
DR   EcoGene; EG11198; glmU.
DR   eggNOG; ENOG4105CAJ; Bacteria.
DR   eggNOG; COG1207; LUCA.
DR   HOGENOM; HOG000283476; -.
DR   InParanoid; P0ACC7; -.
DR   KO; K04042; -.
DR   OMA; FAHARPK; -.
DR   PhylomeDB; P0ACC7; -.
DR   BioCyc; EcoCyc:NAG1P-URIDYLTRANS-MONOMER; -.
DR   BioCyc; MetaCyc:NAG1P-URIDYLTRANS-MONOMER; -.
DR   BRENDA; 2.3.1.157; 2026.
DR   BRENDA; 2.7.7.23; 2026.
DR   SABIO-RK; P0ACC7; -.
DR   UniPathway; UPA00113; UER00532.
DR   UniPathway; UPA00113; UER00533.
DR   UniPathway; UPA00973; -.
DR   EvolutionaryTrace; P0ACC7; -.
DR   PRO; PR:P0ACC7; -.
DR   Proteomes; UP000000318; Chromosome.
DR   Proteomes; UP000000625; Chromosome.
DR   GO; GO:0005829; C:cytosol; IDA:EcoCyc.
DR   GO; GO:0019134; F:glucosamine-1-phosphate N-acetyltransferase activity; IDA:EcoCyc.
DR   GO; GO:0042802; F:identical protein binding; IDA:EcoCyc.
DR   GO; GO:0000287; F:magnesium ion binding; IDA:EcoCyc.
DR   GO; GO:0003977; F:UDP-N-acetylglucosamine diphosphorylase activity; IDA:EcoCyc.
DR   GO; GO:0000902; P:cell morphogenesis; IEA:InterPro.
DR   GO; GO:0071555; P:cell wall organization; IEA:UniProtKB-KW.
DR   GO; GO:0009245; P:lipid A biosynthetic process; IEA:UniProtKB-UniPathway.
DR   GO; GO:0009103; P:lipopolysaccharide biosynthetic process; IEA:InterPro.
DR   GO; GO:0009252; P:peptidoglycan biosynthetic process; IEA:UniProtKB-KW.
DR   GO; GO:0008360; P:regulation of cell shape; IEA:UniProtKB-KW.
DR   GO; GO:0006048; P:UDP-N-acetylglucosamine biosynthetic process; IMP:EcoCyc.
DR   Gene3D; 3.90.550.10; -; 1.
DR   HAMAP; MF_01631; GlmU; 1.
DR   InterPro; IPR005882; Bifunctional_GlmU.
DR   InterPro; IPR001451; Hexapep.
DR   InterPro; IPR018357; Hexapep_transf_CS.
DR   InterPro; IPR025877; MobA-like_NTP_Trfase.
DR   InterPro; IPR029044; Nucleotide-diphossugar_trans.
DR   InterPro; IPR011004; Trimer_LpxA-like.
DR   Pfam; PF00132; Hexapep; 3.
DR   Pfam; PF12804; NTP_transf_3; 1.
DR   SUPFAM; SSF51161; SSF51161; 1.
DR   SUPFAM; SSF53448; SSF53448; 1.
DR   TIGRFAMs; TIGR01173; glmU; 1.
DR   PROSITE; PS00101; HEXAPEP_TRANSFERASES; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acyltransferase; Cell shape;
KW   Cell wall biogenesis/degradation; Cobalt; Complete proteome;
KW   Cytoplasm; Magnesium; Metal-binding; Multifunctional enzyme;
KW   Nucleotidyltransferase; Peptidoglycan synthesis; Reference proteome;
KW   Repeat; Transferase.
FT   CHAIN         1    456       Bifunctional protein GlmU.
FT                                /FTId=PRO_0000068701.
FT   REGION        1    229       Pyrophosphorylase. {ECO:0000255|HAMAP-
FT                                Rule:MF_01631,
FT                                ECO:0000269|PubMed:10428949,
FT                                ECO:0000269|PubMed:8555230}.
FT   REGION       11     14       UDP-GlcNAc binding. {ECO:0000255|HAMAP-
FT                                Rule:MF_01631,
FT                                ECO:0000269|PubMed:10428949,
FT                                ECO:0000269|PubMed:11329257,
FT                                ECO:0000269|PubMed:17473010}.
FT   REGION       81     82       UDP-GlcNAc binding. {ECO:0000255|HAMAP-
FT                                Rule:MF_01631,
FT                                ECO:0000269|PubMed:10428949,
FT                                ECO:0000269|PubMed:11329257,
FT                                ECO:0000269|PubMed:17473010}.
FT   REGION      103    105       UDP-GlcNAc binding. {ECO:0000255|HAMAP-
FT                                Rule:MF_01631,
FT                                ECO:0000269|PubMed:10428949,
FT                                ECO:0000269|PubMed:11329257,
FT                                ECO:0000269|PubMed:17473010}.
FT   REGION      230    250       Linker. {ECO:0000255|HAMAP-Rule:MF_01631,
FT                                ECO:0000269|PubMed:10428949,
FT                                ECO:0000269|PubMed:8555230}.
FT   REGION      251    456       N-acetyltransferase. {ECO:0000255|HAMAP-
FT                                Rule:MF_01631,
FT                                ECO:0000269|PubMed:10428949,
FT                                ECO:0000269|PubMed:8555230}.
FT   REGION      386    387       Acetyl-CoA binding. {ECO:0000255|HAMAP-
FT                                Rule:MF_01631}.
FT   ACT_SITE    363    363       Proton acceptor. {ECO:0000255|HAMAP-
FT                                Rule:MF_01631}.
FT   METAL       105    105       Magnesium or cobalt.
FT                                {ECO:0000269|PubMed:11329257,
FT                                ECO:0000269|PubMed:17473010}.
FT   METAL       227    227       Magnesium or cobalt.
FT                                {ECO:0000269|PubMed:11329257,
FT                                ECO:0000269|PubMed:17473010}.
FT   BINDING      25     25       UDP-GlcNAc. {ECO:0000255|HAMAP-
FT                                Rule:MF_01631}.
FT   BINDING      76     76       UDP-GlcNAc. {ECO:0000255|HAMAP-
FT                                Rule:MF_01631,
FT                                ECO:0000269|PubMed:10428949,
FT                                ECO:0000269|PubMed:11329257,
FT                                ECO:0000269|PubMed:17473010}.
FT   BINDING     140    140       UDP-GlcNAc; via amide nitrogen.
FT                                {ECO:0000255|HAMAP-Rule:MF_01631,
FT                                ECO:0000269|PubMed:10428949,
FT                                ECO:0000269|PubMed:11329257,
FT                                ECO:0000269|PubMed:17473010}.
FT   BINDING     154    154       UDP-GlcNAc. {ECO:0000255|HAMAP-
FT                                Rule:MF_01631,
FT                                ECO:0000269|PubMed:10428949,
FT                                ECO:0000269|PubMed:11329257,
FT                                ECO:0000269|PubMed:17473010}.
FT   BINDING     169    169       UDP-GlcNAc. {ECO:0000255|HAMAP-
FT                                Rule:MF_01631,
FT                                ECO:0000269|PubMed:10428949,
FT                                ECO:0000269|PubMed:11329257,
FT                                ECO:0000269|PubMed:17473010}.
FT   BINDING     227    227       UDP-GlcNAc. {ECO:0000255|HAMAP-
FT                                Rule:MF_01631}.
FT   BINDING     333    333       UDP-GlcNAc. {ECO:0000255|HAMAP-
FT                                Rule:MF_01631,
FT                                ECO:0000269|PubMed:11329257,
FT                                ECO:0000269|PubMed:17473010}.
FT   BINDING     351    351       UDP-GlcNAc. {ECO:0000255|HAMAP-
FT                                Rule:MF_01631,
FT                                ECO:0000269|PubMed:11329257,
FT                                ECO:0000269|PubMed:17473010}.
FT   BINDING     366    366       UDP-GlcNAc. {ECO:0000255|HAMAP-
FT                                Rule:MF_01631,
FT                                ECO:0000269|PubMed:11329257,
FT                                ECO:0000269|PubMed:17473010}.
FT   BINDING     377    377       UDP-GlcNAc. {ECO:0000255|HAMAP-
FT                                Rule:MF_01631,
FT                                ECO:0000269|PubMed:11329257,
FT                                ECO:0000269|PubMed:17473010,
FT                                ECO:0000269|PubMed:21984832}.
FT   BINDING     380    380       Acetyl-CoA; via amide nitrogen.
FT                                {ECO:0000255|HAMAP-Rule:MF_01631,
FT                                ECO:0000269|PubMed:17473010,
FT                                ECO:0000269|PubMed:21984832}.
FT   BINDING     405    405       Acetyl-CoA. {ECO:0000255|HAMAP-
FT                                Rule:MF_01631,
FT                                ECO:0000269|PubMed:11329257,
FT                                ECO:0000269|PubMed:17473010,
FT                                ECO:0000269|PubMed:21984832}.
FT   BINDING     423    423       Acetyl-CoA; via amide nitrogen.
FT                                {ECO:0000255|HAMAP-Rule:MF_01631,
FT                                ECO:0000269|PubMed:11329257,
FT                                ECO:0000269|PubMed:17473010,
FT                                ECO:0000269|PubMed:21984832}.
FT   BINDING     440    440       Acetyl-CoA. {ECO:0000255|HAMAP-
FT                                Rule:MF_01631,
FT                                ECO:0000269|PubMed:11329257,
FT                                ECO:0000269|PubMed:17473010,
FT                                ECO:0000269|PubMed:21984832}.
FT   MUTAGEN      14     14       G->A: 8-fold decrease in
FT                                uridyltransferase activity. Creates
FT                                steric conflict and decreases affinity
FT                                for UTP. {ECO:0000269|PubMed:10428949}.
FT   MUTAGEN      18     18       R->A: Dramatically impairs the
FT                                uridyltransferase activity.
FT                                {ECO:0000269|PubMed:10428949}.
FT   MUTAGEN      25     25       K->A: 8-fold decrease in
FT                                uridyltransferase activity.
FT                                {ECO:0000269|PubMed:10428949}.
FT   MUTAGEN     296    296       C->A: No effect.
FT                                {ECO:0000269|PubMed:9733680}.
FT   MUTAGEN     307    307       C->A: 1350-fold decrease in
FT                                acetyltransferase activity.
FT                                {ECO:0000269|PubMed:9733680}.
FT   MUTAGEN     324    324       C->A: 8-fold decrease in
FT                                acetyltransferase activity.
FT                                {ECO:0000269|PubMed:9733680}.
FT   MUTAGEN     385    385       C->A: No effect.
FT                                {ECO:0000269|PubMed:9733680}.
FT   CONFLICT    186    187       KL -> NV (in Ref. 1; CAA25784).
FT                                {ECO:0000305}.
FT   STRAND        6     12       {ECO:0000244|PDB:1HV9}.
FT   HELIX        17     19       {ECO:0000244|PDB:1HV9}.
FT   HELIX        25     27       {ECO:0000244|PDB:1HV9}.
FT   STRAND       28     30       {ECO:0000244|PDB:1HV9}.
FT   HELIX        35     46       {ECO:0000244|PDB:1HV9}.
FT   STRAND       51     55       {ECO:0000244|PDB:1HV9}.
FT   HELIX        59     65       {ECO:0000244|PDB:1HV9}.
FT   TURN         66     68       {ECO:0000244|PDB:1FXJ}.
FT   STRAND       71     75       {ECO:0000244|PDB:1HV9}.
FT   HELIX        82     89       {ECO:0000244|PDB:1HV9}.
FT   HELIX        90     92       {ECO:0000244|PDB:1HV9}.
FT   STRAND       97    103       {ECO:0000244|PDB:1HV9}.
FT   HELIX       111    120       {ECO:0000244|PDB:1HV9}.
FT   STRAND      125    132       {ECO:0000244|PDB:1HV9}.
FT   STRAND      141    145       {ECO:0000244|PDB:1HV9}.
FT   STRAND      148    153       {ECO:0000244|PDB:1HV9}.
FT   TURN        155    157       {ECO:0000244|PDB:1HV9}.
FT   HELIX       162    164       {ECO:0000244|PDB:1HV9}.
FT   STRAND      167    176       {ECO:0000244|PDB:1HV9}.
FT   HELIX       177    184       {ECO:0000244|PDB:1HV9}.
FT   STRAND      191    193       {ECO:0000244|PDB:1HV9}.
FT   HELIX       198    200       {ECO:0000244|PDB:1HV9}.
FT   HELIX       201    206       {ECO:0000244|PDB:1HV9}.
FT   TURN        207    209       {ECO:0000244|PDB:1HV9}.
FT   STRAND      212    215       {ECO:0000244|PDB:1HV9}.
FT   HELIX       220    223       {ECO:0000244|PDB:1HV9}.
FT   HELIX       233    249       {ECO:0000244|PDB:3TWD}.
FT   STRAND      253    255       {ECO:0000244|PDB:3TWD}.
FT   HELIX       257    259       {ECO:0000244|PDB:3TWD}.
FT   STRAND      260    268       {ECO:0000244|PDB:3TWD}.
FT   STRAND      278    286       {ECO:0000244|PDB:3TWD}.
FT   STRAND      297    300       {ECO:0000244|PDB:3TWD}.
FT   STRAND      314    317       {ECO:0000244|PDB:3TWD}.
FT   STRAND      325    327       {ECO:0000244|PDB:1FXJ}.
FT   STRAND      328    332       {ECO:0000244|PDB:3TWD}.
FT   STRAND      336    338       {ECO:0000244|PDB:4AA7}.
FT   STRAND      343    355       {ECO:0000244|PDB:3TWD}.
FT   STRAND      360    372       {ECO:0000244|PDB:3TWD}.
FT   STRAND      383    385       {ECO:0000244|PDB:3TWD}.
FT   STRAND      387    390       {ECO:0000244|PDB:2OI6}.
FT   STRAND      395    397       {ECO:0000244|PDB:3TWD}.
FT   STRAND      408    415       {ECO:0000244|PDB:3TWD}.
SQ   SEQUENCE   456 AA;  49190 MW;  2F3C5C84F673C8A3 CRC64;
     MLNNAMSVVI LAAGKGTRMY SDLPKVLHTL AGKAMVQHVI DAANELGAAH VHLVYGHGGD
     LLKQALKDDN LNWVLQAEQL GTGHAMQQAA PFFADDEDIL MLYGDVPLIS VETLQRLRDA
     KPQGGIGLLT VKLDDPTGYG RITRENGKVT GIVEHKDATD EQRQIQEINT GILIANGADM
     KRWLAKLTNN NAQGEYYITD IIALAYQEGR EIVAVHPQRL SEVEGVNNRL QLSRLERVYQ
     SEQAEKLLLA GVMLRDPARF DLRGTLTHGR DVEIDTNVII EGNVTLGHRV KIGTGCVIKN
     SVIGDDCEIS PYTVVEDANL AAACTIGPFA RLRPGAELLE GAHVGNFVEM KKARLGKGSK
     AGHLTYLGDA EIGDNVNIGA GTITCNYDGA NKFKTIIGDD VFVGSDTQLV APVTVGKGAT
     IAAGTTVTRN VGENALAISR VPQTQKEGWR RPVKKK
//
